Skip Navigation

Cardiovascular Research 2006 70(3):521-529; doi:10.1016/j.cardiores.2006.02.030
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Keller, D. I.
Right arrow Articles by Chahine, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, D. I.
Right arrow Articles by Chahine, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation

Dagmar I. Kellera,b,1, Hai Huangc,1, Juan Zhaoc, Rudolf Frankd, Vivian Suarezb, Etienne Delacrétaze, Marijke Brinkb, Stefan Osswalda, Nicola Schwicke and Mohamed Chahinec,*

aCardiology Department, University Hospital Basel, Switzerland
bCardiobiology Research Group, University Hospital Basel, Switzerland
cLaval Hospital, Québec Heart Institute, Research Centre, 2725, Chemin Sainte-Foy, Sainte-Foy, Québec, Canada G1V 4G5
dCardiology Department, Tiefenau Hospital, Bern, Switzerland
eSwiss Cardiovascular Center, Bern, Switzerland

* Corresponding author. Tel.: +1 418 656 8711x5447; fax: +1 418 656 4509. Email address: mohamed.chahine{at}phc.ulaval.ca

Objective Brugada syndrome (BS) is an inherited electrical cardiac disorder characterized by right bundle branch block pattern and ST segment elevation in leads V1 to V3 on surface electrocardiogram that can potentially lead to malignant ventricular tachycardia and sudden cardiac death. About 20% of patients have mutations in the only so far identified gene, SCN5A, which encodes the {alpha}-subunit of the human cardiac voltage-dependent sodium channel (hNav1.5). Fever has been shown to unmask or trigger the BS phenotype, but the associated molecular and the biophysical mechanisms are still poorly understood. We report on the identification and biophysical characterization of a novel heterozygous missense mutation in SCN5A, F1344S, in a 42-year-old male patient showing the BS phenotype leading to ventricular fibrillation during fever.

Methods The mutation was reproduced in vitro using site-directed mutagenesis and characterized using the patch clamp technique in the whole-cell configuration.

Results The biophysical characterization of the channels carrying the F1344S mutation revealed a 10mV mid-point shift of the G/V curve toward more positive voltages during activation. Raising the temperature to 40.5°C further shifted the mid-point activation by 18mV and significantly changed the slope factor in Nav1.5/F1344S mutant channels from – 6.49 to – 10.27mV.

Conclusions Our findings indicate for the first time that the shift in activation and change in the slope factor at a higher temperature mimicking fever could reduce sodium currents' amplitude and trigger the manifestation of the BS phenotype.

KEYWORDS Brugada syndrome; Sudden cardiac death; Genetics; SCN5A; Sodium channel; Nav1.5; Fever; Ventricular fibrillation


1 These authors contributed equally to this work.

Time for primary review 14 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.